|
|
||||||||
-Oxa 21:3n-3, Inhibits T Lymphocyte Proliferation, Cytokine Production, Delayed-Type Hypersensitivity, and Carrageenan-Induced Paw Reaction and Selectively Targets Intracellular Signals1





*
Departments of Immunopathology and Paediatrics, University of Adelaide, Womens and Childrens Hospital, North Adelaide, South Australia;
School of Pharmaceutical, Molecular, and Biomedical Sciences, University of South Australia, South Australia;
Research School of Chemistry, Australian National University, Canberra, Australia;
School of Biological Sciences, Flinders University, Adelaide, Australia; and
¶
Peptech Ltd., North Ryde, New South Wales, Australia
A novel polyunsaturated fatty acid (PUFA),
-oxa
21:3n-3, containing an oxygen atom in the
position,
was chemically synthesized, and found to have more selective biological
activity than the n-3 PUFA, docosahexaenoic acid
(22:6n-3) on cells of the immune system. Although
-oxa 21:3n-3 was very poor compared with
22:6n-3 at stimulating oxygen radical production in
neutrophils, it was more effective at inhibiting human T lymphocyte
proliferation (IC50 of 1.9 vs 5.2 µM, respectively).
-Oxa 21:3n-3 also inhibited the production of
TNF-
, IFN-
, and IL-2 by purified human T lymphocytes stimulated
with PHA plus PMA, anti-CD3 plus anti-CD28 mAbs, or PMA plus
A23187. Metabolism of
-oxa 21:3n-3 via the
cyclooxygenase and lipoxygenase pathways was not required for its
inhibitory effects. Consistent with its ability to suppress T
lymphocyte function,
-oxa 21:3n-3 significantly
inhibited the delayed-type hypersensitivity response and
carrageenan-induced paw edema in mice. In T lymphocytes,
-oxa
21:3n-3 inhibited the agonist-stimulated translocation
of protein kinase C-
I and -
, but not -
, -
II, or -
to a
particulate fraction, and also inhibited the activation of the
extracellular signal-regulated protein kinase, but not c-Jun
NH2-terminal kinase and p38. In contrast,
22:6n-3 had no effects on these protein kinase C
isozymes. The increase in antiinflammatory activity and loss of
unwanted bioaction through the generation of a novel synthetic
22:6n-3 analogue provides evidence for a novel strategy
in the development of anti-inflammatory agents by chemically
engineering PUFA.
This article has been cited by other articles:
![]() |
Y. Maeshima, K. Fukatsu, T. Moriya, F. Ikezawa, C. Ueno, D. Saitoh, and H. Mochizuki Influence of Adding Fish Oil to Parenteral Nutrition on Gut-Associated Lymphoid Tissue JPEN J Parenter Enteral Nutr, September 1, 2007; 31(5): 416 - 422. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ferrante, B. S. Robinson, H. Singh, H. P.A. Jersmann, J. V. Ferrante, Z. H. Huang, N. A. Trout, M. J. Pitt, D. A. Rathjen, C. J. Easton, et al. A Novel {beta}-Oxa Polyunsaturated Fatty Acid Downregulates the Activation of the I{kappa}B Kinase/Nuclear Factor {kappa}B Pathway, Inhibits Expression of Endothelial Cell Adhesion Molecules, and Depresses Inflammation Circ. Res., July 7, 2006; 99(1): 34 - 41. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Costabile, C. S. T. Hii, M. Melino, C. Easton, and A. Ferrante The Immunomodulatory Effects of Novel {beta}-Oxa, {beta}-Thia, and {gamma}-Thia Polyunsaturated Fatty Acids on Human T Lymphocyte Proliferation, Cytokine Production, and Activation of Protein Kinase C and MAPKs J. Immunol., January 1, 2005; 174(1): 233 - 243. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. S. Robinson, D. A. Rathjen, N. A. Trout, C. J. Easton, and A. Ferrante Inhibition of Neutrophil Leukotriene B4 Production by a Novel Synthetic N-3 Polyunsaturated Fatty Acid Analogue, {beta}-Oxa 21:3n-3 J. Immunol., November 1, 2003; 171(9): 4773 - 4779. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ariel, N. Chiang, M. Arita, N. A. Petasis, and C. N. Serhan Aspirin-Triggered Lipoxin A4 and B4 Analogs Block Extracellular Signal-Regulated Kinase-Dependent TNF-{alpha} Secretion from Human T Cells J. Immunol., June 15, 2003; 170(12): 6266 - 6272. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |